123 articles for AF Abdel-Magid
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Modulation of the Inhibitors of Apoptosis Proteins (IAPs) Activities for Cancer Treatment.
Therachem Research Medilab (India)
Targeting the Inhibition of Tryptophan 2,3-Dioxygenase (TDO-2) for Cancer Treatment.
Therachem Research Medilab (India)
Potential of Renal Outer Medullary Potassium (ROMK) Channel as Treatments for Hypertension and Heart Failure.
Therachem Research Medilab (India)
Great Therapeutic Potential of Peptidylarginine Deiminase 4 (PAD4) Inhibitors: Treatment of Rheumatoid Arthritis, Epigenetic Tools, Regulation of Pluripotency in Stem Cells, and More.
Therachem Research Medilab (India)
Potential Treatment of Cognitive Impairment in Schizophrenia by Phosphodiesterase 2 (PDE2) Inhibitors.
Therachem Research Medilab (India)
Protease-Activated Receptor 1 (PAR-1) Antagonists as Potential Treatment for Acute Coronary Syndrome.
Therachem Research Medilab (India)
Therapeutic Potential of Smurf-1 Inhibitors for the Treatment of Pulmonary Arterial Hypertension (PAH).
Therachem Research Medilab (India)
Therapeutic Potential for Modulation of Nrf2-Keap-1 Signaling Pathway as Treatment for Diabetes and Other Disorders.
Therachem Research Medilab (India)
Targeting the Follicle Stimulating Hormone Receptor (FSHR) To Treat Fertility Disorders.
Therachem Research Medilab (India)
Glutaminase GLS1 Inhibitors as Potential Cancer Treatment.
Therachem Research Medilab (India)
Potential Use of Inhibitors of Tankyrases and PARP-1 as Treatment for Cancer and Other Diseases.
Therachem Research Medilab (India)
MALT1 Inhibitors May Potentially Treat Lymphomas and Autoimmune Disorders.
Therachem Research Medilab (India)
Inhibition of Histone Demethylases Offers a Novel and Promising Approach for the Treatment of Cancer and Other Diseases.
Therachem Research Medilab (India)
Inhibitors of the Antiapoptotic Myeloid Cell Leukemia-1 (Mcl-1) May Provide Effective Treatment for Cancer.
Therachem Research Medilab (India)
RORc Modulators for the Treatment of Autoimmune Diseases.
Therachem Research Medilab (India)
Nav1.7 Inhibitors: Potential Effective Therapy for the Treatment of Chronic Pain.
Therachem Research Medilab (India)
Kynurenine Monooxygenase (KMO) Inhibitors for the Treatment of Acute Pancreatitis and Neurodegenerative Disorders.
Therachem Research Medilab (India)
Prokineticin Receptor Modulators May Potentially Treat Psychiatric and Neurological Disorders.
Therachem Research Medilab (India)
Fatty Acid Synthase (FASN) Inhibitors as Potential Treatment for Cancer, Obesity, and Liver Related Disorders.
Therachem Research Medilab (India)
Inhibitors of the Epidermal Growth Factor Receptor (EGFR) May Provide Effective Treatment for Lung Adenocarcinoma.
Therachem Research Medilab (India)
Indoleamine 2,3-dioxygenase inhibitors: potential treatment for cancer, sepsis, and more.
Therachem Research Medilab (India)
Prostaglandin EP3 Receptor Antagonists May Provide Novel Treatment for Diabetes.
Therachem Research Medilab (India)
Inhibitors of the PD-1/PD-L1 Pathway Can Mobilize the Immune System: An Innovative Potential Therapy for Cancer and Chronic Infections.
Therachem Research Medilab (India)
Inhibitors of the PAR-2 Signaling Pathway May Treat Pain and Inflammation.
Therachem Research Medilab (India)
Rho kinase inhibitors: potentially versatile therapy for the treatment of cardiovascular diseases and more.
Therachem Research Medilab (India)
Treating pain with somatostatin receptor subtype 4 agonists.
Therachem Research Medilab (India)
Allosteric modulators: an emerging concept in drug discovery.
Therachem Research Medilab (India)
The role of enhancer of zeste homologue 2 inhibitors in controlling epigenetics and their potential for cancer treatment.
Therachem Research Medilab (India)
ROR¿t Modulators Are Potentially Useful for the Treatment of the Immune-Mediated Inflammatory Diseases.
Therachem Research Medilab (India)
MoGAT-2 Inhibitors May Provide Effective Treatment for Hypertriglyceridemia.
Therachem Research Medilab (India)
Pim kinase inhibitors for the treatment of cancer and possibly more.
Therachem Research Medilab (India)
P21-Activated Kinase 4 (PAK4) Inhibitors as Potential Cancer Therapy.
Therachem Research Medilab (India)
RET Kinase Inhibitors May Treat Cancer and Gastrointestinal Disorders.
Therachem Research Medilab (India)
Dual leucine zipper kinase inhibitors: potential treatments for neurodegenerative diseases.
Therachem Research Medilab (India)
Inhibition of O-GlcNAcase (OGA): A Potential Therapeutic Target to Treat Alzheimer's Disease.
Therachem Research Medilab (India)
GnRH antagonists: the promise of treating sex-hormone-related diseases.
Therachem Research Medilab (India)
Liver x receptor agonists for the treatment of coronary heart disease and other disorders.
Therachem Research Medilab (India)
Neutrophil elastase inhibitors as potential anti-inflammatory therapies.
Therachem Research Medilab (India)
Treatment of Immunological or Inflammatory Disorders with ITK Kinase Inhibitors.
Therachem Research Medilab (India)
Inhibitors of Factor XIa and Plasma Kallikrein May Treat Thromboembolic Disorders and Many Diabetes Complications.
Therachem Research Medilab (India)
Selective 5-HT Receptor Modulators May Deliver Focused Targeting with Fewer Adverse Effects.
Therachem Research Medilab (India)
β-Secretase Inhibitors for the Treatment of Alzheimer's Disease and Down's Syndrome.
Therachem Research Medilab (India)
Selective EP4 Antagonist May Be Useful in Treating Arthritis and Arthritic Pain.
Therachem Research Medilab (India)
Inhibitors of factor d may provide a treatment for age-related macular degeneration.
Therachem Research Medilab (India)
Inhibitors of Tropomyosin-Receptor Kinases (Trk's): Potential Pain Therapy and More.
Therachem Research Medilab (India)
Endothelial lipase inhibitors for the treatment of atherosclerosis and cardiovascular disorders.
Therachem Research Medilab (India)
Fighting Obesity and Metabolic Disorders with MGAT-2 Inhibitors.
Therachem Research Medilab (India)
Inhibitors of PI3Kβ as Potential Treatment for Cancer.
Therachem Research Medilab (India)
Targeting CCR2 Receptor To Treat Inflammation Diseases and Disorders.
Therachem Research Medilab (India)
PDE10 Inhibitors as Potential Treatment for Schizophrenia.
Therachem Research Medilab (India)
TRPV4 Antagonists: Potential Treatment for Congestive Heart Failure, Bladder Dysfunctions, and Pain.
Therachem Research Medilab (India)
Aldosterone synthase inhibitors: targeting chronic kidney disease and diabetic nephropathy.
Therachem Research Medilab (India)
Spleen Tyrosine Kinase Inhibitors (SYK) as Potential Treatment for Autoimmune and Inflammatory Disorders: Patent Highlight.
Therachem Research Medilab (India)
Treatment of Obesity and Related Disorders with Acetyl-CoA Carboxylase Inhibitors.
Therachem Research Medilab (India)
GPR119 Modulators for the Treatment of Diabetes, Obesity, and Related Diseases: Patent Highlight.
TBA
BACE-Inhibitors: Potential Treatment of Alzheimer Disease, Dementia, and Related Neurodegenerative Diseases. C. Spiro-Heterocyclic Derivatives: Patent Highlight.
TBA
BACE Inhibitors: Potential Treatment of Alzheimer's Disease, Dementia, and Related Neurodegenerative Disorders (B): 3-Amino-4-fluoro-1H-isoindol Derivatives: Patent Highlight.
TBA
BACE Inhibitors: Potential Treatment of Alzheimer's Disease, Dementia, and Related Neurodegenerative Disorders (A): 5,6-Dihydroimidazo[1,2-a]pyrazin-8-yl-amine Derivatives: Patent Highlight.
TBA
Combatting Drug-Resistant Bacteria with Gyrase and Topoisomerase IV Inhibitors: Patent Highlight.
TBA
Prostaglandin e2 synthase-1 inhibitors as potential treatment for osteoarthritis: patent highlight.
TBA
Inhibitors of the Cyclic GMP-AMP Synthase (cGAS) as Potential Treatment for Autoimmune and Inflammatory Diseases.
PI Health Sciences
Inhibitors of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MK2) as Treatment for Inflammatory Diseases.
PI Health Sciences
The Inhibitors of Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1 (MALT-1) Protease as Potential Treatment of ABC-DLBCL and Similar Diseases.
PI Health Sciences
Targeting the Inhibition of B-Cell Lymphoma 2 Protein for the Treatment of Cancer.
Therachem Research Medilab
Positive Allosteric Modulators of alpha7 Nicotinic Acetylcholine Receptor for the Treatment of Several Central Nervous System Diseases.
Therachem Research Medilab
Inhibitors of Interleukin 4 Induced Protein 1 (IL4I1) as Potential Treatment for Cancer.
Therachem Research Medilab
Plasma Kallikrein Inhibitors as Potential Treatment for Diabetic Macular Edema, Retinal Vein Occlusion, Hereditary Angioedema and Other Related Diseases.
Therachem Research Medilab
Orexin Receptor Agonists as Possible Treatment for Narcolepsy and Idiopathic Hypersomnia.
Therachem Research Medilab
Dual Inhibition of IL-2-Inducible T-Cell Kinase (ITK) and Tropomyosin Receptor Kinase A (TRKA) as Potential Treatment for Atopic Dermatitis and Other Inflammatory and Autoimmune Diseases.
Therachem Research Medilab
Therapeutic Potential of Monoacylglycerol Lipase (MGL) Inhibitors as Treatment for Pain, Depression, Cancers, and Eye Conditions.
Therachem Research Medilab
The Inhibitors of Protein Tyrosine Phosphatase Nonreceptor Type 2 (PTPN2) as Potential Enhancers of Cancer Immunotherapy and Type 1 (PTPN1) as Treatment of Metabolic Diseases.
Therachem Research Medilab
Transient Receptor Potential Ankyrin 1 (TRPA1) Antagonists May Provide a Superior Treatment for Pain and Migraine.
Therachem Research Medilab
Cannabinoid Receptor Agonists for the Potential Treatment of Pain, Neurological Disorders, Fibrotic Diseases, Obesity, and Many More.
Therachem Research Medilab
The Potential of c-KIT Kinase inhibitors in Cancer Treatment.
Therachem Research Medilab
Therapeutic Potential of Autotaxin Inhibitors in Treatment of Interstitial Lung Diseases.
Therachem Research Medilab
Use of Dihydroorotate Dehydrogenase Inhibitors for Treatment of Autoimmune Diseases and Cancer.
Therachem Research Medilab
Antagonists of Orexin Receptors as Potential Treatment of Sleep Disorders, Obesity, Eating Disorders, and Other Neurological and Psychiatric Disorders.
Therachem Research Medilab (India)
Treatment of Metabolic Disorders with CB-1 Receptor Inverse Agonists.
Therachem Research Medilab (India)
Myeloid Cell Leukemia-1 Inhibitors as Emerging Cancer Treatment.
Therachem Research Medilab
Potential of Cyclin-Dependent Kinase Inhibitors as Cancer Therapy.
Therachem Research Medilab
Cancer Immunotherapy through the Inhibition of Diacylglycerol Kinases Alpha and Zeta.
Therachem Research Medilab
Potential Cancer Treatment by Agonists of the Stimulator of Interferon Genes.
Therachem Research Medilab
Inhibitors of Hypoxia-Inducible Factors as Treatment for Cancer.
Therachem Research Medilab
LRRK2 Kinase Inhibitors as Possible Therapy for Parkinson's Disease and Other Neurodegenerative Disorders.
Therachem Research Medilab
Potential of ROCK Inhibitors as Treatment for Cardiovascular Diseases, Cancer, and More.
Therachem Research Medilab
Targeting the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Protein for the Treatment of Cystic Fibrosis.
Therachem Research Medilab (India)
Potential Treatment for Neuropsychiatry Disorders with TRPC5 Modulators.
Therachem Research Medilab (India)
Second-Generation FGFR Inhibitors for the Treatment of Cancers Harboring Mutated FGFRs.
Therachem Research Medilab
Treatment of Diabetes, Obesity, Dyslipidemia, and Related Disorders with GPR119 Agonists.
Therachem Research Medilab
ASK1: A Therapeutic Target for the Treatment of Multiple Diseases.
Therachem Research Medilab
Lysophosphatidic Acid Receptor 1 Antagonists for the Treatment of Fibrosis.
Therachem Research Medilab
Inhibitors of KRAS May Potentially Provide Effective Cancer Treatment.
Therachem Research Medilab
Tankyrase inhibitors: potential treatment of hyperproliferative diseases.
Therachem Research Medilab (India)
Inhibition of CK2: An Attractive Therapeutic Target for Cancer Treatment.
Therachem Research Medilab (India)
Sphingosine-1-phosphate (S1P) Receptor Modulators Provide Potential for Diverse Treatments.
Therachem Research Medilab (India)
Histone Deacetylase 4 (HDAC4) Inhibitors: A Promising Treatment for Huntington's Disease.
Therachem Research Medilab (India)
FPRL-1 Receptor Modulators May Provide Treatment for Inflammation.
Therachem Research Medilab (India)
Potassium channel modulators as possible treatment for pain: patent highlight.
Therachem Research Medilab (India)
Therapeutic Potential of FXR Agonists in the Treatment of Multiple Diseases.
Therachem Research Medilab
GPR40 Receptor Agonists for the Treatment of Type 2 Diabetes and Related Diseases.
Therachem Research Medilab
Potential of PDE10A Inhibitors as Treatment for Schizophrenia and Other Neurological Disorders.
Therachem Research Medilab
Lysine-Specific Demethylase 1 (LSD1) Inhibitors as Potential Treatment for Different Types of Cancers.
Therachem Research Medilab (India)
Selective Inhibitors of Phosphodiesterase 4B (PDE-4B) May Provide a Better Treatment for CNS, Metabolic, Autoimmune, and Inflammatory Diseases.
Therachem Research Medilab (India)
Selective Estrogen Receptor Degraders (SERDs): A Promising Treatment to Overcome Resistance to Endocrine Therapy in ERα-Positive Breast Cancer.
Therachem Research Medilab (India)
Inhibitors of CD73 May Provide a Treatment for Cancer and Autoimmune Diseases.
Therachem Research Medilab (India)
Potential of PI3Kβ Inhibitors in the Treatment of Cancer and Other Diseases.
Therachem Research Medilab (India)
Plasma Kallikrein Inhibitors for the Treatment of Retinal Vascular Permeability Associated with Diabetic Retinopathy and Diabetic Macular Edema.
Therachem Research Medilab (India)
Janus-Associated Kinase 1 (JAK1) Inhibitors as Potential Treatment for Immune Disorders.
Therachem Research Medilab (India)